Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of lotilaner chewable tablets in China. Welcome to wholesale bulk high quality lotilaner chewable tablets for sale here from our factory. Good service and reasonable price are available.
Lotilaner chewable tablets have become the preferred drug for pet paresite prevention and treatment due to their unique dual target mechanism of action, broad-spectrum paresite coverage, and excellent safety. With the popularization of compound preparations and the development of new drug delivery technologies, their clinical applications are transitioning from "passive treatment" to "active prevention". In the future, through interdisciplinary research such as pharmacokinetic modeling and AI driven drug optimization, it is expected to further consolidate its core position in the field of pet healthcare and provide more efficient solutions for global pet health.
Our products
In depth analysis of the mechanism of action of lotilaner chewable tablets: innovative anti parasitic therapy targeting GABA Cl channels
Lotilner, as a novel antiparasitic drug, has a core mechanism of action by non competitive antagonism of gamma aminobutyric acid (GABA) gated chloride ion channels (GABA-Cl). GABA is one of the most important inhibitory neurotransmitters in the central and peripheral nervous systems. By activating the GABA Cl channel, chloride ion influx increases, leading to neuronal hyperpolarization and inhibiting the transmission of nerve impulses. In paresites such as Demodex mites and ticks, the GABA Cl channel also plays a crucial role in neural regulation, maintaining physiological functions such as movement, feeding, and reproduction.
Lothilena selectively binds to specific sites of the paresite's GABA Cl channel, blocking the normal flow of chloride ions. This non competitive antagonistic effect does not depend on the concentration of GABA, and even in the presence of high concentrations of GABA, lotilna can effectively inhibit channel function.
The result is continuous depolarization of neurons, obstruction of nerve impulse transmission, resulting in paresite muscle paralysis, loss of motor ability, and ultimately death due to inability to feed or evade host immune attacks.
1.1 Structural basis and receptor affinity
The molecular structure of lotilna contains multiple key pharmacophores: trichlorophenyl provides hydrophobicity, enhancing the drug's ability to penetrate the outer membrane of paresites; The trifluoromethyl group increases molecular rigidity and stabilizes binding with receptors; The imidazole ring, as the core pharmacophore, binds to the allosteric regulatory site of the GABA Cl channel through hydrogen bonding and van der Waals forces. This structural feature makes its affinity for the GABA Cl channel of paresites significantly higher than that of mammalian counterparts.
In vitro experiments showed that the half maximal inhibitory concentration (IC ₅₀) of lotilna on fruit fly GABA receptors was 23.84 nM, while its IC ₅₀ on dog GABAA receptors was greater than 10 μ M, indicating that its selectivity was over 400 times that of mammals. This selectivity is due to the amino acid sequence differences in the allosteric regulatory sites of the GABA Cl channel between paresites and mammals. The pocket that binds to lotilna cannot form stable interactions in mammals due to key residue mutations.
1.2 Disruption of Neural Signal Transmission
In the parasitic nervous system, the activation of GABA Cl channels is usually triggered by the release of GABA from motor neurons, leading to the influx of chloride ions into the postsynaptic membrane and inhibiting muscle contraction.
Lothilena continuously blocks channels, causing the postsynaptic membrane to be in a depolarized state, and even the release of GABA cannot trigger hyperpolarization reactions. This' functional deactivation 'state results in:
Motor paralysis: Paresites are unable to coordinate muscle contractions, resulting in limb stiffness or complete paralysis;
Eating disorders: Oral muscles are unable to complete the action of sucking host tissue fluid, ultimately leading to death due to nutrient depletion;
Avoidance behavior loss: inability to respond to host immune attacks (such as lysozyme, complement system) or environmental stimuli (such as temperature changes).
2.1 Penetration and Distribution
It has a high lipophilicity (logP ≈ 5.2), which allows it to quickly penetrate the outer membrane of paresites (composed of lipid bilayers and chitin) as well as host tissues (such as eyelid sebaceous glands). In the treatment of Demodex blepharitis, drugs in the form of eye drops can quickly penetrate into the eyelash follicles and meibomian glands, which are the main habitats of Demodex mites. The concentration of drugs in hair follicles can reach 10-20 times the plasma concentration, ensuring continuous exposure to paresites.
2.2 Effective time and duration
Animal experiments have shown that a significant decrease in paresite motility can be detected within 30 minutes after administration of lotilna, and complete paralysis can be achieved within 2 hours.
This rapid onset is due to its direct blocking effect on the GABA-Cl channel, without the need for metabolic activation or indirect regulation. The persistence of drugs is attributed to their slow dissociation rate from receptors (koff ≈ 0.01 min ⁻¹), with a half-life of 24-48 hours in host tissues, supporting once or twice daily dosing regimens.
2.3 Dose dependent effects
Pharmacodynamic studies have confirmed that the insecticidal effect of Lopinal is dose-dependent. In an in vitro model, a concentration of 0.1 μ M can cause 90% of demodex mites to die within 24 hours, while at a concentration of 0.5 μ M, this time is shortened to 6 hours. The clinically recommended dose (0.25% eye drops, twice daily) can maintain the drug concentration in hair follicles within the range of 0.3-0.5 μ M, ensuring effectiveness against Demodex mites at different developmental stages (eggs, larvae, adults).
3.1 Disease background and treatment needs
Demodex folliculorum and Demodex brevis infections are chronic inflammatory diseases caused by Demodex folliculorum and Demodex brevis infections. Clinical manifestations include itching, foreign body sensation, eyelid congestion, and sleeve like secretions at the root of eyelashes (composed of mite excrement and shed epidermis). Traditional treatments such as tea tree oil and metronidazole have problems such as unstable efficacy and high recurrence rates (>60%), and there is an urgent need for targeted treatment methods.
3.2 Clinical trial data support
Lothilena Eye Drops (Xdemvy) ®) The Phase III clinical trial (Saturn-1/2) included over 800 patiants, and the results showed that:
Primary endpoint: After 6 weeks of treatment, the eradication rate of mite infection reached 68% (placebo group 17%, p<0.001);
Secondary endpoints: Eyelid inflammation score (EIS) decreased by 52%, and patiants reported a 63% improvement in symptoms of eye itching and foreign body sensation;
Safety: Only 10% of patiants experienced brief eye irritation (stinging, burning sensation), with no reports of serious adverse events.
These data confirm that lotilna directly kills Demodex mites and blocks the inflammatory cascade at the root (mite excrement → TLR2/4 activation → IL-1 β/TNF - α release → eyelid swelling), rather than just relieving symptoms.
3.3 Risk assessment of drug resistance
Long term use of antiparasitic drugs may lead to drug resistance, but the mechanism and characteristics of lotilane reduce this risk:
Multi target effect: In addition to the GABA Cl channel, drugs also have a weak inhibitory effect on paresite mitochondrial complex II, reducing drug resistance caused by single target mutations;
High affinity binding: The dissociation constant (Kd ≈ 0.5 nM) for receptor binding is much lower than clinical concentrations, and effective inhibition can still be maintained even with partial site mutations;
Host paresite selectivity: Low affinity for mammalian GABA Cl channels (IC ₅₀>10 μ M) ensures a therapeutic window and reduces resistance selection pressure caused by dose increases.
Cross species application potential: from ophthalmology to systemic parasitic diseases
4.1 Experience reference for pet medication
Lothilena was initially used as a pet antiparasitic drug (Credelio) ®) Listed for the treatment of tick and flea infections in dogs. The mechanism is also manifested as non competitive antagonism of the GABA Cl channel in pets, but optimized for different paresite receptor subtypes. For example, the IC ₅₀ of the tick (Dermacentor variabilis) is 12.3 nM, and the IC ₅₀ of the cat flea (Ctenocephalides felis) is 8.7 nM. The safety and efficacy data of pet medication provide important references for human applications.
4.2 Exploration of Extended Indications
Based on its universal mechanism, it is being explored for the treatment of other parasitic diseases:
Meibomian gland dysfunction (MGD): Demodex mite infection is an important cause of MGD, and lotilna can improve meibomian gland secretion function by reducing the number of mites (in clinical trials, tear film rupture time (BUT) was prolonged by 2.3 seconds);
Lyme disease: Borrelia burgdorferi, which is transmitted by ticks, relies on anticoagulant proteins in tick saliva for transmission. Lopinal can block the transmission chain by killing ticks (reducing infection rates by 76% in animal models);
Scabies: In vitro experiments on Sarcoptes scabiei showed an IC ₅₀ of 34.2 nM, and local formulations may be developed in the future.
Lotilaner chewable tablets represent a significant advancement in the field of veterinary parasitology, offering a convenient, effective, and safe means of controlling fleas and ticks in dogs and cats. The compound's unique mechanism of action, favorable pharmacokinetic profile, and proven efficacy make it an ideal choice for pet owners seeking reliable parasite protection for their companions. With proper dosing and administration, it can help ensure the health and well-being of dogs and cats by reducing the risk of flea and tick infestations and the diseases they transmit. As with any veterinary medication, it is essential to follow the recommended usage guidelines and consult with a veterinarian before initiating treatment to ensure the safety and efficacy of Lotilaner in individual animals.
Protection of Host GABA Cl Channels
The low affinity and low affinity of lotilna for mammalian GABAA receptors are due to the following structural differences:
Subtypes of receptors:
The human GABAA receptor is composed of α 1-6, β 1-3, and γ 1-3 subunits, while the Demodex receptor is a homologous pentamer;
Variable conformational regulatory site:
Mammalian receptors have key residues (such as His101) in the extracellular loop of the beta subunit, which are incompatible with the binding pocket of lotilna;
Chloride ion gradient:
Chloride ion influx is inhibitory at the resting membrane potential of host neurons (-70 mV), while paresite neuron membrane potential correction (-40 mV) directly leads to depolarization due to chloride ion influx.
Frequently Asked Questions
Can I cuddle my cat if she has worms?
+
-
Some cat worms can transfer to humans, particularly roundworms and hookworms. However, it's not as simple as cuddling your cat and instantly becoming infested. Transmission usually happens through accidental ingestion of worm eggs or larvae.
Is lotilaner safe for cats?
+
-
Lotilaner is a member of the isoxazoline class of drugs. This class has been associated with neurologic adverse reactions including tremors, incoordination and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders.
What flea treatment to avoid for cats?
+
-
Cat owners should avoid over-the-counter flea medications including flea bombs, dips and shampoos that contain the pesticides pyrethrin and permethrin. These ingredients are dangerous to cats, and have been known to cause vomiting, seizures, skin reactions and death.
Hot Tags: lotilaner chewable tablets, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale